CELLPLY SRL
Desconocido
ONCOSMART: ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics
CELLPLY SRL
tramitó un
H2020:
H2020-EIC-SMEInst-2018-2020
ONCOSMART is the first In-Vitro Diagnostic (IVD) system that determines the effectiveness of anticancer drugs for a specific patient, testin...
2018-07-10 - 2021-08-31 | Financiado
2018-07-10 - 2021-08-31 | Financiado
Oncosmart: ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics
CELLPLY SRL
tramitó un
H2020:
H2020-SMEInst-2016-2017
The advent of personalized cancer care demands for distributed diagnostic solutions to support clinical decisions and selection of the best...
2016-12-07 - 2017-03-31 | Financiado
2016-12-07 - 2017-03-31 | Financiado
* No se disponen de datos de la empresa actual.